BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Of INPULSIS Trials Demonstrates Efficacy Of OFEV (Nintedanib) Across A Range Of IPF Patients Using Broader Diagnostic Criteria

  June 27, 2016

   · 

  9 min read
• FDA

  Health Canada Approves Janssen’s Invega Trinza for Schizophrenia

  June 27, 2016

   · 

  4 min read
• Biotech Bay

  Global Blood Therapeutics Announces Closing Of Public Offering Of Common Stock

  June 27, 2016

   · 

  3 min read
• Policy

  Advanced Accelerator Applications Announces FDA Priority Review for Lutathera; PDUFA Target Action Date is December 28, 2016

  June 27, 2016

   · 

  1 min read
• Deals

  Jazz Pharma Announces Expiration Of HSR Waiting Period For Proposed Celator Pharma Acquisition

  June 27, 2016

   · 

  3 min read
• VMS Rehab Systems Eyes Anomaly In Stock Price

  June 27, 2016

   · 

  2 min read
• Business

  ErgoMed Expands to the U.S. With New Boston Office For its Subsidiary PrimeVigilance

  June 27, 2016

   · 

  5 min read
• Policy

  BioVentrix Receives CE Marking Certification For Revivent TC, The First Minimally Invasive Heart Failure Treatment To Restore The Left Ventricle

  June 27, 2016

   · 

  4 min read
• Pharm Country

  Relmada Therapeutics Announces Notice Of Allowance For U.S. Patent Covering D-Methadone, An NMDA Receptor Antagonist, For The Treatment Of Depression

  June 27, 2016

   · 

  5 min read
• Pharm Country

  Pinnacle 21 Announces Clinical Data Standardization Services

  June 27, 2016

   · 

  3 min read